NCT06589791Completed
A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
This is a survey-based study with the objective to understand the awareness, perceptions and potential clinical management patterns among Chinese cardiologists and nephrologists towards the role of systemic inflammation in patients with ASCVD and CKD in real-world clinical setting.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1500 (actual)
- First submitted
- 6 Sept 2024
- Start date
- 9 Sept 2024
- Primary completion date
- 5 Dec 2024
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Chronic kidney disease
- NCT number
- NCT06589791
What you commit to
- Study type: Observational
- Participants enrolled: 1500
- From 9 Sept 2024 to the primary completion date, 5 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unwilling to provide informed consent
- Insufficient number of patients with ASCVD and CKD
- Do not fulfil inclusion criteria.
Who the study is looking for
- Work in cardiology, internal medicine, or nephrology department
- Specialize in one of the following: coronary interventional cardiology, HF, general cardiology, preventive cardiology, cardiac rehabilitation or nephrology
- Practice at consultant level for 3+ years after standardized training for resident physicians or 3+ years' working experience as a specialist
- Manage at least 20 adult patients with ASCVD and CKD (not dialysis-only) every month
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Novo Nordisk Shanghai Pharmaceuticals Co., Ltd Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.